Watson Biotech is planning a change in the company's control, and trading will be suspended starting March 17.

2026-03-18 06:40:53

Beijing Business Daily News (Reporter Wang Yinhao, Song Yuying): On March 16, Watson Bio announced that the company is planning to issue A-shares to specific investors, which may lead to a change in control of the company. To protect the interests of investors and prevent abnormal fluctuations in the company’s stock price, the company’s stock will be suspended from trading starting from the open on March 17, 2026 (Tuesday), with an expected suspension period of no more than two trading days.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes